Business Context and Reporting Period
This Form 8-K Current Report was filed by Assembly Biosciences, Inc. on February 4, 2022, covering events occurring on February 1, 2022. The filing details the approval of a new executive and employee compensation structure.
Key Financial Metrics
The filing does not provide specific revenue, profit, cash flow, margin, debt, or liquidity figures. The document focuses exclusively on the terms of a new cash bonus plan.
Material Changes
On February 1, 2022, the Compensation Committee approved the 2022 Corporate Bonus Plan, effective January 1, 2022. This plan introduces a performance-based cash bonus structure for eligible employees, including named executive officers, based on corporate and individual objectives.
Guidance, Outlook, and Plan Details
- Plan Administration: Administered by the Compensation Committee, with authority delegated to the CEO for non-executive participants.
- Performance Metrics: Bonuses are based on Corporate Objectives (financial and operational) and Individual Objectives.
- Objective Weighting:
- Chief Executive Officer: 100% Corporate Objectives.
- C-Level (other than CEO): 75% Corporate Objectives.
- Senior Vice President/Vice President: 50% Corporate Objectives.
- Below Vice President: 25% Corporate Objectives.
- Bonus Targets (Percentage of Base Salary):
- CEO: 75%.
- Executive Participants and Non-Executive Participants (VP level and above): 30% to 55%.
- Non-Executive Participants (below VP level): Up to 28%.
- Payout Range: 0 to 1.5 times the target bonus.
- Payment Timing: Expected in the first quarter following the performance period, no later than March 15.
- Eligibility: Employees must commence employment by October 31 of the performance period and remain employed through the payment date.
Investor Verification Checklist
- Review the full text of the 2022 Corporate Bonus Plan (Exhibit 10.1) for specific definitions of "Corporate Objectives" and "Individual Objectives."
- Verify the specific financial and operational metrics the Board will assign to Corporate Objectives within 90 days of the performance period start.
- Monitor future filings for the actual payout amounts and the degree to which objectives were met.
- Confirm the impact of this plan on the company's future operating expenses and cash burn rate.